Skip to main content
Thorax logoLink to Thorax
. 1989 Aug;44(8):631–633. doi: 10.1136/thx.44.8.631

A phase II study of oral etoposide in elderly patients with small cell lung cancer.

E F Smit 1, D N Carney 1, P Harford 1, D T Sleijfer 1, P E Postmus 1
PMCID: PMC461991  PMID: 2477908

Abstract

Thirty five previously untreated patients with small cell lung cancer older than 70 years were treated with oral etoposide (800 mg/m2 over five consecutive days) every four weeks. Twenty two patients had extensive disease and 13 limited disease. The overall response rate was 71%. The median survival for patients with limited diseases was 16 (range 6-32) months and for patients with extensive disease nine (range 4-17) months. There was mild haematological toxicity and alopecia but no major toxicity. It is concluded that etoposide in this dose regimen is an effective and well tolerated treatment for elderly patients with small cell lung cancer.

Full text

PDF
631

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan S. G., Gregor A., Cornbleet M. A., Leonard R. C., Smyth J. F., Grant I. W., Crompton G. K. Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer. Cancer Chemother Pharmacol. 1984;13(2):106–108. doi: 10.1007/BF00257124. [DOI] [PubMed] [Google Scholar]
  2. Ihde D. C. Current status of therapy for small cell carcinoma of the lung. Cancer. 1984 Dec 1;54(11 Suppl):2722–2728. doi: 10.1002/1097-0142(19841201)54:2+<2722::aid-cncr2820541419>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  3. Morgan D. A., Gilson D., Fletcher J. Vincristine and etoposide: an effective chemotherapy regimen with reduced toxicity in extensive small-cell lung cancer. Eur J Cancer Clin Oncol. 1987 Jun;23(6):619–621. doi: 10.1016/0277-5379(87)90256-2. [DOI] [PubMed] [Google Scholar]
  4. Poplin E., Thompson B., Whitacre M., Aisner J. Small cell carcinoma of the lung: influence of age on treatment outcome. Cancer Treat Rep. 1987 Mar;71(3):291–296. [PubMed] [Google Scholar]
  5. Samet J., Hunt W. C., Key C., Humble C. G., Goodwin J. S. Choice of cancer therapy varies with age of patient. JAMA. 1986 Jun 27;255(24):3385–3390. [PubMed] [Google Scholar]
  6. Stewart D. J., Nundy D., Maroun J. A., Tetreault L., Prior J. Bioavailability, pharmacokinetics, and clinical effects of an oral preparation of etoposide. Cancer Treat Rep. 1985 Mar;69(3):269–273. [PubMed] [Google Scholar]
  7. Teeter S. M., Holmes F. F., McFarlane M. J. Lung carcinoma in the elderly population. Influence of histology on the inverse relationship of stage to age. Cancer. 1987 Sep 15;60(6):1331–1336. doi: 10.1002/1097-0142(19870915)60:6<1331::aid-cncr2820600628>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES